|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.04 EUR | -0.18% |
|
-1.22% | +6.98% |
| 07-30 | Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials | RE |
| 07-28 | Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | -0.18% | -1.22% | +6.98% | +12.43% | +95.77% | 162B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GILD Stock
- GIS Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
